Bill to allow pharmacist–physician collaborative practice moves forward
A Senate bill enabling collaborative practice agreements to permit pharmacists to perform federally authorized point-of-care tests and deliver treatment under physician protocols passed a floor amendment and received a second reading; the measure requires boards to adopt regulations before implementation.
The full story
Lawmakers advanced Senate Bill 449 after adopting a committee amendment that defines collaborative practice agreements between physicians and pharmacists and preserves regulatory oversight. Mr. Sessions described the change as allowing "pharmacists to perform simple federally approved lab tests called CLIA-waived tests and if the test come back positive, they provide treatment for that illness," adding the amendment requires identical protocols authorized by the board of pharmacy and the board of medical examiners before implementation.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in